Extranodal NK/T-cell Lymphoma, Nasal Type: Report of a Case and Review of the South African Literature
DOI:
https://doi.org/10.17159/Keywords:
Tygerberg hospital, Nasal mass, Nasal obstruction, Ear, Nose and Throat (ENT) clinicAbstract
A 76-year-old African female was referred to the Ear, Nose and Throat (ENT) clinic at Tygerberg hospital in Cape Town, South Africa, with history of a progressively enlarging painful right-sided nasal mass with nasal obstruction. Her medical history was significant for controlled hypertension and type 2 diabetes mellitus. Clinical examination revealed swelling of the right nasolabial region with associated cellulitis and a necrotic right nasal mass with crusting (Figure 1). Flexible endoscopy of the left nasal cavity showed septal perforation. Haematological tests revealed anaemia and leucocytosis with elevated levels of urea, creatinine, c-reactive protein and erythrocyte sedimentation rate (ESR). A surgical biopsy of the nasal mass was performed under local anaesthesia. A pus swab was also obtained for microbiological culture which identified Staphylococcus aureus and Streptococcus gordonnii. Subsequently treatment with the antibiotic, Clindamycin, was initiated. The patient was then discharged from the hospital, pending histology results. Histological examination of the biopsy obtained under local anaesthesia showed a small specimen with fragmentation artifacts and
necrosis. A repeat biopsy was recommended. On follow-up, the patient’s condition had worsened. She presented with delirium, dehydration and a significant increase in the size of the nasal mass. The patient was subsequently taken to the operating theatre. Intraoperative exploration of the right nasal cavity disclosed a foul smelling necrotic tissue involving the anterior third of the nasal floor and septum, with extension into the oral cavity and destruction of the anterior maxillary alveolar cortex (Figure 2). Given the clinical history of diabetes mellitus, an invasive fungal infection (Mucormycosis) was highly suspected. However, biopsy from the right nasal region showed superficial mucosa with ulceration and dense chronic inflammation with no evidence of fungal organisms. Further laboratory investigations were undertaken, including antineutrophil cytoplasmic antibodies (ANCA) test, serum angiotensin-converting enzyme (ACE) test, and syphilis serology, to rule out the destructive midface lesions, polyangiitis with granulomatosis (Wegener’s granulomatosis), sarcoidosis and syphilis respectively. All test results were negative.
Downloads
References
1. McBride P. Photographs of a case of rapid destruction of the nose and face. Laryngol. 1897;12:64-6.
2. Williams HL. LXXXVII Lethal Granulomatous Ulceration Involving the Midline Facial Tissues. Ann Otol Rhinol Laryngol. 1949;58(4):1013-54.
3. Harabuchi Y, Kataura A, Kobayashi K, Yamamoto T, Yamanaka N, Hirao M, et al. Lethal midline granuloma (peripheral T-cell lymphoma) after lymphomatoid papulosis. Cancer. 1992;70(4):835-9.
4. Ng CS, Chan JK, Lo ST. Expression of natural killer cell markers in non-Hodgkin’s lymphomas. Hum Pathol. 1987;18(12):1257-62.
5. Ishii Y, Yamanaka N, Ogawa K, Yoshida Y, Takami T, Matsuura A, et al. Nasal T-cell lymphoma as a type of so-called “lethal midline granuloma”. Cancer. 1982;50(11):2336-44.
6. Yamanaka N, Kataura A, Minase T, Sambe S, Ishii Y. Midfacial T-cell lymphoma: characterization by monoclonal antibodies. Ann Otol Rhinol Laryngol. 1985;94(2):207-11.
7. Harabuchi Y, Yamanaka N, Kataura A, Imai S, Kinoshita T, Osato T. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet. 1990;335(8682):128-30.
8. Ayee R, Ofori MEO, Wright E, Quaye O. Epstein Barr virus associated lymphomas and epithelial cancers in humans. J Cancer. 2020;11(7):1737.
9. Liu J, Song B, Fan T, Huang C, Xie C, Li J, et al. Pathological and clinical characteristics of 1,248 non-Hodgkin’s lymphomas from a regional cancer hospital in Shandong, China. Asian Pac J Cancer Prev. 2011;12(11):3055-61.
10. International T-Cell Lymphoma Project. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26(25):4124-30.
11. Rüdiger T, Weisenburger DD, Anderson JR, Armitage JO, Diebold J, MacLennan KA, et al. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin’s Lymphoma Classification Project. Ann Oncol. 2002;13(1):140-9.
12. Lima M. Aggressive mature natural killer cell neoplasms: from epidemiology to diagnosis. Orphanet J Rare Dis. 2013;8:1-10.
13. Takahara M, Kumai T, Kishibe K, Nagato T, Harabuchi Y. Extranodal NK/T-cell lymphoma, nasal type: genetic, biologic, and clinical aspects with a central focus on Epstein–Barr virus relation. Microorganisms. 2021;9(7):1381.
14. Xu G, Wang H, Xie K, He G, Du Z. Analysis of clinicopathological features and prognostic factors of 62 nasal NK/T-cell lymphomas. J Clin Otorhinolaryngol. 2007;21:932-4.
15. Missaoui N, Mestiri S, Bouriga A, Abdessayed N, Belakhdher M, Ghammem M, et al. Extranodal NK/T-cell lymphoma in Tunisia: clinicopathological features, immunophenotype and EBV infection. J Egypt Natl Canc Inst. 2019;31:1-8.
16. Abubakar M, Shuaibu IY, Chitumu D, Liman AA, Suleiman DE. Extranodal NK/T cell lymphoma: diagnostic challenges in a resource-constrained setting. Sub-Saharan Afr J Med. 2019;6(1):49-53.
17. Tlholoe MM, Kotu M, Khammissa RA, Bida M, Lemmer J, Feller L. Extranodal natural killer/T-cell lymphoma, nasal type: ‘midline lethal granuloma’. A case report. Head Face Med. 2013;9:1-5.
18. Mankgele M, Goqwana L, Philip V, Waja F, Lakha A, Perner Y, et al. An unusual case of lymphoma—a case of extranodal NK/T-cell lymphoma, nasal type. Egypt J Otolaryngol. 2022;38(1):114.
19. Li W. The 5th Edition of the World Health Organization Classification of Hematolymphoid Tumors. Exon Publications; 2022. p.1-21.
20. Tse E, Zhao WL, Xiong J, Kwong YL. How we treat NK/T-cell lymphomas. J Hematol Oncol. 2022;15(1):74.
21. Tse E, Kwong YL. How I treat NK/T-cell lymphomas. Blood. 2013;121(25):4997-5005.
22. Yan Z, Yao S, Wang Z, Zhou W, Yao Z, Liu Y. Treatment of extranodal NK/T-cell lymphoma: From past to future. Front Immunol. 2023;14:1088685.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.